Abstract
A large body of data has been amassed which convincingly demonstrates that the immune system and the nervous system extensively interact (Ader, Cohen, & Felten, 1991; Miller, In Press). Immune cells and tissues express receptors for a wide range of transmitters associated with and regulated by the nervous system including neuro-transmitters, peptides and hormones, and nervous system innervation of lymphoid tissues has been well characterized. Moreover, the presence of soluble immune products (cytokines) and their receptors have been found in multiple nervous system and endocrine tissues (Besedovsky & del Rey, 1996). Alterations of nervous system function by exposure to a variety of stressors has been shown to result in dramatic changes in immune system function, and exposure to cytokines or various types of immune activation has been shown to significantly alter CNS function (Miller, In Press; McEwen, Biron, Brunson, Bulloch, Chambers, Dhabhar, Goldfarb, Kitson, Miller, Spencer, & Weiss, 1997; Kent, Bluthe, Kelley, & Dantzer, 1992). Given the vast potential for mutual regulation involving the immune system and the brain, there has been considerable interest in the possibility that immune system processes may be involved in the pathophysiology of psychiatric syndromes including major depression. One possible mechanism whereby the immune system might contribute to the development of pathology which manifests as depressive symptomatology involves the capacity of cytokines to inhibit functioning of the receptors for glucocorticoids, thus inducing a state of glucocorticoid resistance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ader, R., Cohen, N., & Feiten, D. (1991). Psychoneuroimmunology II. New York, Academic Press.
Besedovsky, H. O. & del Rey, A. (1996). Immune-neuro-endocrine interactions: Facts and hypotheses. Endocrine Reviews, 17, 64–102.
Dunn, A.J. & Wang. J. (1995). Cytokine effects on CNS biogenic amines. Neuroimmunomodulation, 2, 319–328.
Ericsson, A., Kovacs, J., & Sawchenko, P. E. (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. Journal of Neuroscience, 14, 897–913.
Guiochon-Mantel, A., Delabre, K., Lescop, P., & Milgrom, E. (1996). Intracellular traffic of steroid hormone receptors. Journal of Steroid Biochemistry and Molecular Biology, 56, 3–9.
Holsboer, F. & Barden, N. (1996). Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews, 17, 187–205.
Kent. S., Bluthe. R. M., Kelley, K. W., & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13, 24–28.
Labeur, M.S., Arzt, E., Wiegers, G. J., Holsboer, F., & Reul, J. M. H. M. (1995). Long-term intracerebroven-tricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinology, 136, 2678–2688.
Maes. M. (1993). A review on the acute phase response in major depression. Reviews in the Neurosciences, 4, 407–416.
Maes. M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. Journal of Affective Disorders. 34, 301–309.
McEwen, B.S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson. R. P., Miller. A. H., Spencer, R. L., & Weiss, J. M. (1997). The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine, and immune interactions. Brain Research Reviews, 23, 79–133.
Miller, A. H., Pearce. B. D., Ruzek, M. C., & Biron, C. A. (In Press). Interactions between the hypothalamic-pituitary-adrenal axis and immune system during viral infection: pathways for environmental effects on disease expression. In B. S. McEwen (Ed.), Handbook of Physiology.
Miller. A.H. (1998). Neuroendocrine and immune system interactions in stress and depression. Psychiatric Clinics of North America. Philadelphia, W. B. Saunders, 21, 443–463.
Miller, A.H., Spencer, R. L., Tanapat, P., Leung, J. J., Dhabhar, F. S., McEwen, B. S., & Biron, C. A. (1997). Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues. Psychoneuroendocrinology. 22, 455–474.
Musselman, D.L., Pisell. T. L., Lewison, B., Pearce, B. D., Knight, B.T., Ninan, P. T., Nemeroff, C. B., & Miller, A. H. (1997). Interleukin-6 plasma concentrations in cancer patients with depression. Society for Neuroscience Abstract, 23, 996.
Norbiato, G., Bevilacqua, M., & Vago, T. (1997). Glucocorticoids and the immune system in AIDS. Psychoneuroendocrinology, 22, S19–S25.
Owens, M.J. & Nemeroff, C.B. (1993). The role of CRF in the pathophysiology of affective disorders: laboratory and clinical studies, Ciba Foundation Symposium on Corticotropin-Releasing Factor 172 (W. W. Vale, Ed.), New York, John Wiley & Sons, 293–316.
C.M., Pearce, B. D., Pisell, T. L., & Miller, A. H. (1996). Interleukin-1 alpha inhibits neucleocyto-plasmic traffic of the glucocorticoid receptor. International Congress of the International Society for Neuroimmunomodulation Abstract.
Pariante, C.M., Nemeroff, C. B., & Miller, A. H. (1995). Glucocorticoid receptors in depression. Israel Journal of Medical Science, 31, 705–712.
Pariante, C.M., Pearce, B. D., Pisell, T. L., Owens, M. J., & Miller, A. H. (1997). Steroid-Independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Molecular Pharmacology, 52, 571–581.
Pepin, M.C., Pothier, F., & Barden, N. (1992). Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression, Molecular Pharmacology, 42, 991–995.
Pepin, M.-C., Govindan, M. V., & Barden, N. (1992). Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Molecular Pharmacology, 41, 1016–1022.
Ribeiro, S. C. M., Tandon, R., Grunhaus, L., & Greden, J. F. (1993). The DST as a predictor of outcome in depression: a meta-analysis. American Journal of Psychiatry, 150, 1618–1629.
Rivier, C. (1995). Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Frontiers in Neuroendocrinology, 16, 151–182.
Rossby, S. P., Nalepa, I., Huang, M., Perrin, C., Burt, A. M., Schmidt, D. E., Gillespie, D. D., & Sulser, F. (1995). Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Research, 687, 79–82.
Ruzek, M., Miller, A. H., Pearce, B. D., Spencer, R. L., & Biron, C. A. (1997). Evidence for endogenous glucocorticoid protection against MCMV-induced lethality. Society for Neuroscience Abstract, 23, 715.
Ruzek, M.C., Miller, A. H., Opal, S. M., Pearce, B. D., & Biron, C. A. (1997). Characterization of early cytokine responses and an IL-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. Journal of Experimental Medicine, 185, 1185–1192.
Schulte, H. M., Bamberger, C. M., Elsen, H., Herrmann, G., Bamberger, ••, & Barth, J. (1994). Systemic interleukin-a alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormomone in humans. European Journal of Clinical Investigation, 24, 773–777.
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996). Indicators of immune activation in major depression. Psychiatry Research, 64, 161–167.
Spencer, R. L., Miller, A. H., Stein, M., & McEwen, B. S. (1991). Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Research, 549, 236–246.
Weidenfeld, J. & Yirmiya, R. (1996). Effects of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress. Neuroimmunomodulation, 3, 352–357.
Yirmiya, R. (1996). Endotoxin produces a depressive-like episode in rats. Brain Research, 711, 163–174.
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993). Exposure to physical and psychological Stressors elevates plasma interleukin 6: Relationship to the activation of the hypothalamic-pituitary-adrenal axis. Endocrinology, 133, 2523–2530.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Miller, A.H., Pariante, C.M., Pearce, B.D. (1999). Effects of Cytokines on Glucocorticoid Receptor Expression And Function. In: Dantzer, R., Wollman, E.E., Yirmiya, R. (eds) Cytokines, Stress, and Depression. Advances in Experimental Medicine and Biology, vol 461. Springer, New York, NY. https://doi.org/10.1007/978-0-585-37970-8_7
Download citation
DOI: https://doi.org/10.1007/978-0-585-37970-8_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46135-4
Online ISBN: 978-0-585-37970-8
eBook Packages: Springer Book Archive